Title:
【発明の名称】インテグリン受容体アンタゴニスト
Document Type and Number:
Japanese Patent JP2001511452
Kind Code:
A
Abstract:
Compounds of the formula (I) are disclosed which are dual fibrinogen receptor and vitronectin receptor antagonists and are useful in the treatment of atherosclerosis, in the prevention of restenosis and in the prevention of tumor metastasis and tumor growth.
Inventors:
Dirk Healding
James Martin Samanen
James Martin Samanen
Application Number:
JP2000504863A
Publication Date:
August 14, 2001
Filing Date:
August 04, 1998
Export Citation:
Assignee:
SMITHKLINE BEECHAM CORPORATION
International Classes:
C07D223/16; A61K31/5513; A61K31/553; A61K31/554; A61P9/10; A61P43/00; C07D267/14; C07D281/10; C07D401/14; C07D403/14; (IPC1-7): C07D223/16; A61K31/5513; A61K31/553; A61P9/10; A61P43/00; C07D267/14; C07D281/10; C07D403/14
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)